Management of common bacterial infections of the skin

delayed breast cellulitis, recurrent cellulitis, recurrent erysipelas, soft tissue infections, Dermatolymphangioadenitis (DLA), Flesh Eating Bacteria, Bacterial Infections, Strep Infections, bacterial cellulitis, prophylactic antibiotics

Moderators: Birdwatcher, jenjay, patoco, Senior Moderators

Management of common bacterial infections of the skin

Postby patoco » Fri Mar 07, 2008 8:04 am

Management of common bacterial infections of the skin.

(Lymphedema referenced as a risk factor for impetigo, erysipelas and folliculitis)

Curr Opin Infect Dis. 2008 Apr

Bernard P.
Department of Dermatology, Robert Debré Hospital, Reims, France.

PURPOSE OF REVIEW: Bacterial skin infections commonly encountered in the community include impetigo, folliculitis/furunculosis, simple abscesses, erysipelas and other nonnecrotizing cellulitis. The review focuses on recent epidemiological, bacteriological and therapeutic
advances.

RECENT FINDINGS: Impetigo and erysipelas occur in about 20 and 1 person/1000/year, respectively. Main risk factors for erysipelas are
toe-web intertrigo and lymphedema. The true incidence of furunculosis
is unknown, whereas outbreaks in small communities are reported
worldwide. Staphylococcus aureus is the predominant pathogen for
impetigo and furunculosis, and methicillin-resistant strains play a
growing role in both diseases. Erysipelas are mainly caused by
streptococci, whereas local complications (i.e. abscesses or blisters)
may be due to staphylococci, including methicillin-resistant strains
in involved geographic areas. Recent trends for treating impetigo and
furunculosis predate community-acquired methicillin-resistant S.
aureus. For outbreaks of furunculosis, stringent decolonization
measures are showing promise, whereas there is no validated
therapeutic regimen for chronic furunculosis. Current trends for
erysipelas involve ambulatory treatments and reduced duration of
antibiotics.

SUMMARY: Despite better epidemiological or bacteriological knowledge of common bacterial skin infections, the exact role of methicillin-resistant staphylococci needs regular surveys in involved geographic areas. Antibiotic treatment must be active on staphylococci and, to a lesser degree, on streptococci.

http://www.co-infectiousdiseases.com/pt ... 00001432...

* * * *

Pat O'Connor
Lymphedema People
http://www.lymphedemapeople.com
User avatar
patoco
Site Admin
 
Posts: 2175
Joined: Thu Jun 08, 2006 9:07 pm

Return to Lymphedema Infections, Cellulitis, lymphangitis

Who is online

Users browsing this forum: No registered users and 2 guests